Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
10.94
Dollar change
-0.23
Percentage change
-2.06
%
Index- P/E2.10 EPS (ttm)5.21 Insider Own31.39% Shs Outstand760.14M Perf Week-6.81%
Market Cap8.82B Forward P/E- EPS next Y-1.16 Insider Trans-1.21% Shs Float552.92M Perf Month3.01%
Income4.47B PEG- EPS next Q-0.28 Inst Own50.53% Short Float5.59% Perf Quarter-0.45%
Sales123.24M P/S71.54 EPS this Y557.08% Inst Trans2.60% Short Ratio4.20 Perf Half Y7.89%
Book/sh7.57 P/B1.45 EPS next Y-122.11% ROA91.47% Short Interest30.93M Perf Year47.64%
Cash/sh8.28 P/C1.32 EPS next 5Y- ROE123.54% 52W Range7.01 - 13.24 Perf YTD-2.58%
Dividend Est.- P/FCF- EPS past 5Y21.79% ROI68.29% 52W High-17.37% Beta1.33
Dividend TTM- Quick Ratio27.77 Sales past 5Y571.16% Gross Margin72.86% 52W Low56.06% ATR (14)0.44
Dividend Ex-Date- Current Ratio27.79 EPS Y/Y TTM411.84% Oper. Margin-850.46% RSI (14)50.10 Volatility2.88% 3.86%
Employees904 Debt/Eq0.08 Sales Y/Y TTM185.76% Profit Margin3624.14% Recom1.15 Target Price16.71
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q1322.86% Payout- Rel Volume0.86 Prev Close11.17
Sales Surprise16.89% EPS Surprise2051.46% Sales Q/Q117.80% EarningsFeb 13 BMO Avg Volume7.36M Price10.94
SMA202.47% SMA500.58% SMA2002.98% Trades Volume6,346,898 Change-2.06%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Outperform $17
Jan-05-24Initiated Piper Sandler Overweight $20
Dec-12-23Initiated Deutsche Bank Buy $14
Oct-17-23Initiated Guggenheim Buy $17
Jun-08-23Initiated BofA Securities Neutral $10.50
Oct-27-22Initiated JP Morgan Overweight $7
May-23-22Initiated SVB Leerink Outperform $6
Apr-29-22Initiated Cantor Fitzgerald Overweight $15
Dec-15-21Initiated Goldman Buy $15
Nov-08-21Initiated H.C. Wainwright Buy $14
Apr-12-24 11:09AM
Apr-02-24 07:00AM
Mar-27-24 01:55PM
Mar-26-24 06:22PM
Mar-17-24 08:50AM
07:04AM Loading…
Mar-14-24 07:04AM
Feb-15-24 02:45AM
Feb-13-24 07:00AM
Feb-10-24 02:55AM
Jan-30-24 04:05PM
Dec-27-23 08:05PM
Dec-20-23 04:30PM
Dec-14-23 09:00AM
Nov-28-23 07:00AM
02:38AM
08:00AM Loading…
Nov-27-23 08:00AM
Nov-14-23 01:00PM
Nov-13-23 07:00AM
Nov-10-23 08:00AM
Oct-30-23 05:30PM
Oct-24-23 08:00AM
Oct-23-23 03:02PM
10:31AM
09:52AM
06:55AM
03:49AM
01:00AM
Oct-13-23 08:00AM
Oct-05-23 05:01AM
Oct-03-23 07:00AM
05:00AM Loading…
Sep-30-23 05:00AM
Sep-26-23 06:00AM
Sep-11-23 08:00AM
Sep-09-23 10:51AM
Aug-17-23 04:05PM
Aug-14-23 07:00AM
Aug-03-23 04:05PM
Aug-02-23 04:05PM
Jul-27-23 08:00AM
Jul-26-23 10:21AM
Jul-13-23 05:50PM
Jul-11-23 08:00AM
Jun-28-23 08:57AM
07:00AM
Jun-26-23 04:05PM
Jun-22-23 07:30AM
Jun-21-23 05:00PM
May-16-23 07:00AM
Apr-04-23 07:37AM
07:37AM
Mar-28-23 08:00AM
Mar-15-23 07:45AM
Mar-14-23 04:07PM
08:00AM
Mar-07-23 08:00AM
Feb-21-23 08:32PM
Feb-13-23 04:17PM
07:00AM
Feb-02-23 09:14PM
Feb-01-23 04:05PM
Jan-30-23 08:00AM
Jan-04-23 06:05AM
Dec-07-22 06:30AM
Dec-01-22 08:00AM
Nov-14-22 07:00AM
Nov-10-22 09:00AM
Nov-08-22 06:15AM
Nov-07-22 04:01PM
Oct-18-22 04:00PM
Aug-30-22 07:00AM
Aug-16-22 11:44AM
Aug-15-22 07:00AM
Aug-14-22 10:53AM
Aug-03-22 07:00AM
Jul-23-22 09:00AM
Jun-30-22 09:18AM
Jun-28-22 06:27AM
06:10AM
06:00AM
Jun-15-22 04:30PM
May-24-22 06:00AM
May-19-22 04:30PM
May-16-22 07:00AM
May-09-22 11:16AM
May-02-22 07:00AM
Apr-20-22 07:00AM
Apr-13-22 07:00AM
Mar-25-22 08:01AM
Mar-24-22 07:00AM
Mar-11-22 04:45PM
Mar-07-22 11:18AM
Feb-28-22 06:01AM
Feb-14-22 07:00AM
Feb-07-22 07:00AM
Jan-25-22 04:30PM
Jan-05-22 04:30PM
10:39AM
Dec-16-21 10:00AM
Nov-15-21 07:00AM
Nov-08-21 04:45PM
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Venker EricPresident & COOFeb 09 '24Option Exercise3.8596,950373,258629,157Feb 09 09:00 PM
Venker EricPresident & COOFeb 09 '24Sale10.9296,9501,058,694532,207Feb 09 09:00 PM
Ramaswamy Vivek10% OwnerJan 02 '24Sale11.053,000,00033,150,00051,929,426Jan 03 04:56 PM
Venker EricChief Operating OfficerOct 05 '23Sale10.11153,0271,547,103595,397Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 04 '23Option Exercise3.85153,027589,154748,424Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 03 '23Option Exercise3.85606,2212,333,9511,201,618Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 03 '23Sale10.25606,2216,213,765595,397Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 02 '23Option Exercise3.85440,7521,696,8951,036,149Oct 04 09:30 PM
Roivant Sciences Ltd.DirectorOct 02 '23Buy38.001,526,31658,000,00879,805,331Oct 04 05:15 PM
Venker EricChief Operating OfficerOct 02 '23Sale10.80440,7524,760,122595,397Oct 04 09:30 PM
SVF Investments (UK) Ltd10% OwnerSep 28 '23Sale12.6010,000,000126,000,00073,031,667Oct 02 09:00 PM
QVT Financial LPDirector by DeputizationSep 28 '23Sale11.5510,000,000115,500,000100,804Oct 02 08:43 PM
Gold Daniel AllenDirectorSep 28 '23Sale11.5510,000,000115,500,000100,804Oct 02 08:55 PM
MANCHESTER KEITH SDirectorSep 28 '23Sale11.556,896,14479,650,4635,023,787Oct 02 09:05 PM
Venker EricPresident & COOSep 27 '23Option Exercise3.85500,0001,925,0001,095,397Sep 29 09:30 PM
Venker EricPresident & COOSep 27 '23Sale13.02500,0006,510,000595,397Sep 29 09:30 PM
Kumar RakhiChief Accounting OfficerSep 08 '23Option Exercise6.4899,350643,788297,300Sep 12 09:30 PM
Venker EricChief Operating OfficerSep 08 '23Option Exercise3.85106,430409,756718,243Sep 12 09:32 PM
Venker EricChief Operating OfficerSep 08 '23Sale12.19106,4301,297,382611,813Sep 12 09:32 PM
Kumar RakhiChief Accounting OfficerSep 08 '23Sale12.1899,3501,210,083197,950Sep 12 09:30 PM
Venker EricChief Operating OfficerSep 06 '23Option Exercise3.855,92622,815617,739Sep 06 09:30 PM
Venker EricChief Operating OfficerSep 06 '23Sale11.855,92670,223611,813Sep 06 09:30 PM
Venker EricChief Operating OfficerSep 05 '23Option Exercise3.8573,275282,109685,088Sep 06 09:30 PM
Kumar RakhiChief Accounting OfficerSep 05 '23Option Exercise6.481,72411,172199,674Sep 07 09:30 PM
Venker EricChief Operating OfficerSep 05 '23Sale11.9273,275873,438611,813Sep 06 09:30 PM
Kumar RakhiChief Accounting OfficerSep 05 '23Sale12.001,72420,688197,950Sep 07 09:30 PM
Venker EricChief Operating OfficerSep 01 '23Option Exercise3.8514,76356,838626,576Sep 06 09:30 PM
Venker EricChief Operating OfficerSep 01 '23Sale11.9014,763175,680611,813Sep 06 09:30 PM
Venker EricChief Operating OfficerAug 14 '23Option Exercise3.8559,811230,272687,729Aug 16 09:34 PM
Venker EricChief Operating OfficerAug 14 '23Sale11.8959,811711,153627,918Aug 16 09:34 PM
Venker EricChief Operating OfficerAug 03 '23Option Exercise3.8544,629171,822672,547Aug 07 09:30 PM
Kumar RakhiChief Accounting OfficerAug 03 '23Option Exercise6.483,68123,853203,009Aug 03 09:30 PM
Venker EricChief Operating OfficerAug 03 '23Sale11.9344,629532,424627,918Aug 07 09:30 PM
Kumar RakhiChief Accounting OfficerAug 03 '23Sale12.003,68144,172199,328Aug 03 09:30 PM
Venker EricChief Operating OfficerAug 02 '23Option Exercise3.8516,39763,128644,315Aug 02 09:30 PM
Venker EricChief Operating OfficerAug 02 '23Sale11.8616,397194,468627,918Aug 02 09:30 PM
Venker EricChief Operating OfficerAug 01 '23Option Exercise3.8561,397236,378689,315Aug 02 09:30 PM
Kumar RakhiChief Accounting OfficerAug 01 '23Option Exercise6.483362,177199,664Aug 03 09:30 PM
Venker EricChief Operating OfficerAug 01 '23Sale11.9261,397731,852627,918Aug 02 09:30 PM
Kumar RakhiChief Accounting OfficerAug 01 '23Sale12.003364,032199,328Aug 03 09:30 PM
Venker EricChief Operating OfficerJul 31 '23Option Exercise3.85117,372451,882745,290Aug 02 09:30 PM
Venker EricChief Operating OfficerJul 31 '23Sale11.91117,3721,397,901627,918Aug 02 09:30 PM
Venker EricChief Operating OfficerJul 27 '23Option Exercise3.8523,62290,945651,540Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 27 '23Sale10.9823,622259,370627,918Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 26 '23Option Exercise3.8573,568283,237701,486Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 26 '23Sale10.9173,568802,627627,918Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 25 '23Option Exercise3.8528,344109,124656,262Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 25 '23Sale10.8628,344307,816627,918Jul 27 09:30 PM
Venker EricPresident & COOJul 24 '23Option Exercise3.8533,081127,362677,296Jul 24 09:31 PM
Venker EricPresident & COOJul 24 '23Sale10.9333,081361,575644,215Jul 24 09:31 PM
Venker EricPresident & COOJul 21 '23Option Exercise3.85181,998700,692826,213Jul 24 09:31 PM
Venker EricPresident & COOJul 21 '23Sale11.13181,9982,025,638644,215Jul 24 09:31 PM
Venker EricPresident & COOJul 20 '23Option Exercise3.85159,387613,640803,602Jul 24 09:31 PM
Venker EricPresident & COOJul 20 '23Sale11.31159,3871,802,667644,215Jul 24 09:31 PM
Kumar RakhiChief Accounting OfficerJul 18 '23Option Exercise6.4810064882,228Jul 18 09:30 PM
Kumar RakhiChief Accounting OfficerJul 18 '23Sale12.001001,20082,128Jul 18 09:30 PM
Kumar RakhiChief Accounting OfficerJul 14 '23Option Exercise6.485353,46782,663Jul 18 09:30 PM
Kumar RakhiChief Accounting OfficerJul 14 '23Sale12.005356,42082,128Jul 18 09:30 PM
Sumitomo Chemical Co., Ltd.10% OwnerJun 22 '23Sale8.6015,116,277129,999,98271,251,083Jun 26 04:05 PM
VIKING GLOBAL PERFORMANCE LLC10% OwnerJun 22 '23Sale9.9013,000,000128,700,000641,010Jun 26 05:10 PM
VIKING GLOBAL INVESTORS LP10% OwnerJun 22 '23Sale9.9013,000,000128,700,000641,010Jun 26 05:11 PM
Venker EricPresident & COOJun 09 '23Option Exercise3.85299,3841,152,628959,481Jun 09 09:32 PM
Kumar RakhiChief Accounting OfficerJun 09 '23Option Exercise5.1243,893224,732242,475Jun 13 09:31 PM
Venker EricPresident & COOJun 09 '23Sale9.91299,3842,966,895660,097Jun 09 09:32 PM
Kumar RakhiChief Accounting OfficerJun 09 '23Sale9.9343,893435,857198,582Jun 13 09:31 PM
Venker EricPresident & COOJun 07 '23Option Exercise3.85201774660,298Jun 09 09:32 PM
Venker EricPresident & COOJun 07 '23Sale9.852011,980660,097Jun 09 09:32 PM
Venker EricPresident & COOMay 23 '23Option Exercise3.854151,598676,183May 25 09:30 PM
Venker EricPresident & COOMay 23 '23Sale9.854154,088675,768May 25 09:30 PM
Venker EricPresident & COOMay 09 '23Option Exercise3.85238,724919,087914,492May 11 09:33 PM
Venker EricPresident & COOMay 09 '23Sale9.23238,7242,203,423675,768May 11 09:33 PM
Venker EricPresident & COOMay 08 '23Option Exercise3.8561,206235,643736,974May 08 09:30 PM
Venker EricPresident & COOMay 08 '23Sale8.9361,206546,570675,768May 08 09:30 PM
Venker EricPresident & COOMay 04 '23Option Exercise3.8588,838342,026764,606May 08 09:30 PM
Venker EricPresident & COOMay 04 '23Sale8.3088,838737,355675,768May 08 09:30 PM
Venker EricPresident & COOMay 03 '23Option Exercise3.85118,760457,226794,528May 03 09:30 PM
Venker EricPresident & COOMay 03 '23Sale8.40118,760997,584675,768May 03 09:30 PM
Venker EricPresident & COOMay 02 '23Option Exercise3.85109,074419,935784,842May 03 09:30 PM
Kumar RakhiChief Accounting OfficerMay 02 '23Option Exercise3.8515,51759,740215,656May 03 09:30 PM
Venker EricPresident & COOMay 02 '23Sale8.29109,074904,223675,768May 03 09:30 PM
Kumar RakhiChief Accounting OfficerMay 02 '23Sale8.4215,517130,653200,139May 03 09:30 PM
Kumar RakhiChief Accounting OfficerMay 01 '23Option Exercise3.8562,219239,543262,358May 03 09:30 PM
Venker EricPresident & COOMay 01 '23Option Exercise3.8561,155235,447736,923May 03 09:30 PM
Kumar RakhiChief Accounting OfficerMay 01 '23Sale8.5862,219533,839200,139May 03 09:30 PM
Venker EricPresident & COOMay 01 '23Sale8.5961,155525,321675,768May 03 09:30 PM
Venker EricPresident & COOApr 28 '23Option Exercise3.8575,823291,919751,591Apr 28 09:35 PM
Kumar RakhiChief Accounting OfficerApr 28 '23Option Exercise3.8571,989277,158272,128Apr 28 09:35 PM
Venker EricPresident & COOApr 28 '23Sale8.4775,823642,221675,768Apr 28 09:35 PM
Kumar RakhiChief Accounting OfficerApr 28 '23Sale8.4771,989609,747200,139Apr 28 09:35 PM
Venker EricPresident & COOApr 27 '23Option Exercise3.8573,514283,029749,282Apr 28 09:35 PM
Kumar RakhiChief Accounting OfficerApr 27 '23Option Exercise3.8670,969273,871271,108Apr 28 09:35 PM
Venker EricPresident & COOApr 27 '23Sale8.5173,514625,604675,768Apr 28 09:35 PM
Kumar RakhiChief Accounting OfficerApr 27 '23Sale8.5170,969603,946200,139Apr 28 09:35 PM
Kumar RakhiChief Accounting OfficerApr 26 '23Option Exercise3.9287,830344,528287,969Apr 28 09:35 PM
Venker EricPresident & COOApr 26 '23Option Exercise3.8572,906280,688748,674Apr 28 09:35 PM
Kumar RakhiChief Accounting OfficerApr 26 '23Sale8.6887,830762,364200,139Apr 28 09:35 PM
Venker EricPresident & COOApr 26 '23Sale8.6672,906631,366675,768Apr 28 09:35 PM